U.S. markets open in 4 hours 16 minutes
  • S&P Futures

    3,317.00
    +17.75 (+0.54%)
     
  • Dow Futures

    27,364.00
    +221.00 (+0.81%)
     
  • Nasdaq Futures

    11,200.25
    +50.75 (+0.46%)
     
  • Russell 2000 Futures

    1,496.20
    +7.40 (+0.50%)
     
  • Crude Oil

    40.01
    +0.21 (+0.53%)
     
  • Gold

    1,886.50
    -21.10 (-1.11%)
     
  • Silver

    23.72
    -0.81 (-3.29%)
     
  • EUR/USD

    1.1714
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    0.6640
    0.0000 (0.00%)
     
  • Vix

    26.25
    -1.53 (-5.51%)
     
  • GBP/USD

    1.2723
    -0.0014 (-0.11%)
     
  • USD/JPY

    104.9770
    +0.0530 (+0.05%)
     
  • BTC-USD

    10,475.60
    -66.16 (-0.63%)
     
  • CMC Crypto 200

    221.85
    +8.09 (+3.79%)
     
  • FTSE 100

    5,954.35
    +124.89 (+2.14%)
     
  • Nikkei 225

    23,346.49
    -13.81 (-0.06%)
     

Wuxi Biologics: Covid-19 Antibody Products Out By Year End

Aug.18 -- Chris Chen, chief executive officer at Wuxi Biologics Cayman Inc., discusses first-half earnings, the progress they’re making on Covid-19 treatments and the company’s expansion plans. He speaks exclusively on “Bloomberg Markets: China Open.”